(Q41003711)

English

A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection

scientific article published on 12 September 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection (English)

1 reference

Europe PubMed Central

25 September 2017

attenuated vaccine

1 reference

based on heuristic

inferred from title

Mycobacterium tuberculosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Xuefeng Yuan

1

1 reference

Europe PubMed Central

25 September 2017

Xindong Teng

2

1 reference

Europe PubMed Central

25 September 2017

Yukai Jing

3

1 reference

Europe PubMed Central

25 September 2017

Jilei Ma

4

1 reference

Europe PubMed Central

25 September 2017

Maopeng Tian

5

1 reference

Europe PubMed Central

25 September 2017

Qi Yu

6

1 reference

Europe PubMed Central

25 September 2017

Lei Zhou

7

1 reference

Europe PubMed Central

25 September 2017

Ruibo Wang

8

1 reference

Europe PubMed Central

25 September 2017

Weihua Wang

9

1 reference

Europe PubMed Central

25 September 2017

Li Li

10

1 reference

Europe PubMed Central

25 September 2017

Xionglin Fan

11

1 reference

Europe PubMed Central

25 September 2017

language of work or name

0 references

publication date

12 September 2015

1 reference

Europe PubMed Central

25 September 2017

Applied Microbiology and Biotechnology

1 reference

Europe PubMed Central

25 September 2017

99

1 reference

Europe PubMed Central

25 September 2017

24

1 reference

Europe PubMed Central

25 September 2017

10587-10595

1 reference

Europe PubMed Central

25 September 2017

https://scigraph.springernature.com/pub.10.1007/s00253-015-6962-x

0 references

Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

The success and failure of BCG - implications for a novel tuberculosis vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Tuberculosis vaccine development at a divide

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

The immune response in tuberculosis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens.

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Expression of the Mycobacterium tuberculosis acr-coregulated genes from the DevR (DosR) regulon is controlled by multiple levels of regulation

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Central memory CD4+ T cells are responsible for the recombinant Bacillus Calmette-Guérin ΔureC::hly vaccine's superior protection against tuberculosis

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Mycobacterium tuberculosis-specific CD8+ T cells and their role in immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00253-015-6962-X

21 January 2018

Identifiers

10.1007/S00253-015-6962-X

1 reference

Europe PubMed Central

25 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41003711&oldid=2092947281"